Technology News

In this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo discuss the latest news in eye care and chat with Wiley A. Chambers, MD, about his career in the FDA and his plans for retirement.

Oftentimes, the younger generation has insight into the future of our field, especially when it comes to incorporating new technological advances.

In this episode, Dagny Zhu, MD, talks diversity in leadership with Lori Tierney, as well as her journey from vision science to president of Americas for Johnson & Johnson Vision.

Glaucoma is a major blinding disease. The onset is hidden, and early diagnosis is difficult. Cost-effective screening tools are lacking, and often we diagnose the disease when the optic nerve damage is irreversible.

John A. Hovanesian, MD, FACS, and Jim Mazzo sit down with guests Eric D. Donnenfeld, MD, Calvin C. Roberts, MD, Mark L. Baum and Jeannette Bankes to discuss private equity, industry breakthroughs and more.

Ikerian AG and its subsidiary RetinAI have launched RetinAI Discovery for Clinics, a software solution designed to improve treatment workflows, referrals and patient management decisions for eye care providers.

In this episode, Dagny Zhu, MD, and Laura Periman, MD, chat with Kendra Hileman on how to get involved in clinical research.

Artificial intelligence offers incredible opportunities in medicine, helping us cut through petabytes of data to define trends in disease and potentially discover new treatments.

The Notal OCT Analyzer is the AI segmentation algorithm that analyzes each of the daily OCT scans obtained by patients as part of a neovascular age-related macular degeneration remote-monitoring paradigm.

Common sight-threatening retinal diseases seen by all comprehensive ophthalmologists include wet age-related macular degeneration, geographic atrophy and diabetic macular edema.